Next Article in Journal
Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey
Previous Article in Journal / Special Issue
Warfarin: The End or the End of One Size Fits All Therapy?
Open AccessEditorial

Preface to Special Issue on ‘Cytochrome P450 Variation in Pharmacogenomics’

1
Department of Medicinal Chemistry, University of Washington, Seattle, WA 98195, USA
2
Department of Internal Medicine and Molecular Pharmacology and Physiology, and the Center for Personalized Medicine and Genomics, University of South Florida Morsani College of Medicine, Tampa, FL 33612, USA
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2018, 8(3), 23; https://doi.org/10.3390/jpm8030023
Received: 2 July 2018 / Revised: 3 July 2018 / Accepted: 3 July 2018 / Published: 4 July 2018
(This article belongs to the Special Issue Cytochrome P450 Variation in Pharmacogenomics)
No abstract available
View Full-Text
Show Figures

Figure 1

MDPI and ACS Style

Rettie, A.E.; Liggett, S.B. Preface to Special Issue on ‘Cytochrome P450 Variation in Pharmacogenomics’. J. Pers. Med. 2018, 8, 23.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop